SpyGlass Pharma, Inc. (SGP)Healthcare | Biotechnology | Irvine, United States | NasdaqGS
24.00 USD
-0.72
(-2.913%) ⇩
(Oct. 16, 2026, 4 p.m.
EDT)
After hours: 24.00 |
Hot Take ↕ | Oct. 10, 2026, 8:25 a.m. EDT
The immediate outlook is clouded by severe technical weakness and a lack of catalysts. Over the last two weeks, the stock has drifted lower, closing below the 50-day moving average and failing to find support near the 200-day line, which suggests sellers are in control. While the analyst consensus rates this as a 'Strong Buy' with a significant upside target, this sentiment appears disconnected from the current price action and the company's financial reality. The business is burning cash with negative operating cash flow and negative earnings, relying entirely on future drug trials for recovery. With no dividend to provide income and a lock-up expiration still months away, there is no floor to catch a falling knife. The statistical models offer no directional guidance, reinforcing the view that the short-term path is uncertain and likely to remain under pressure until a clinical milestone or earnings surprise forces a re-rating. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.068357 |
| AutoARIMA | 0.068479 |
| MSTL | 0.070795 |
| AutoTheta | 0.075768 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 44% |
| H-stat | 0.26 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.409 |
| Excess Kurtosis | -0.94 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.702 |
| Market Cap | 802,751,488 |
| Forward P/E | -8.53 |
| Website | https://www.spyglasspharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.090909064 |
| Address1 | 15,326 Alton Parkway |
| All Time High | 32.44 |
| All Time Low | 17.06 |
| Ask | 30.95 |
| Ask Size | 2 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 70,690 |
| Average Daily Volume3 Month | 100,279 |
| Average Volume | 100,279 |
| Average Volume10Days | 70,690 |
| Bid | 17.57 |
| Bid Size | 2 |
| Book Value | 6.947 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 24.0 |
| Current Ratio | 25.057 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 24.84 |
| Day Low | 23.94 |
| Debt To Equity | 0.702 |
| Display Name | SpyGlass Pharma |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -61,091,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -9.334 |
| Enterprise Value | 570,197,504 |
| Eps Current Year | -2.49889 |
| Eps Forward | -2.81442 |
| Eps Trailing Twelve Months | -2.51 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 26.4964 |
| Fifty Day Average Change | -2.4964008 |
| Fifty Day Average Change Percent | -0.0942166 |
| Fifty Two Week Change Percent | -9.090906 |
| Fifty Two Week High | 32.44 |
| Fifty Two Week High Change | -8.439999 |
| Fifty Two Week High Change Percent | -0.2601726 |
| Fifty Two Week Low | 17.06 |
| Fifty Two Week Low Change | 6.9400005 |
| Fifty Two Week Low Change Percent | 0.40679958 |
| Fifty Two Week Range | 17.06 - 32.44 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,770,388,200,000 |
| Float Shares | 6,496,601 |
| Forward Eps | -2.81442 |
| Forward P E | -8.527512 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 76 |
| Fullday Change | -0.7199993 |
| Fullday Change Percent | -2.9126186 |
| Fullday Price | 24.0 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04275 |
| Held Percent Institutions | 0.94681 |
| Implied Shares Outstanding | 33,447,979 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-02-06 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California. |
| Long Name | SpyGlass Pharma, Inc. |
| Market | us_market |
| Market Cap | 802,751,488 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_618742691 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -56,053,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 941,895,088 |
| Number Of Analyst Opinions | 6 |
| Open | 24.74 |
| Operating Cashflow | -46,558,000 |
| Operating Margins | 0.0 |
| Phone | 949 284 6904 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 24.0 |
| Post Market Time | 1,792,180,813 |
| Previous Close | 24.72 |
| Price Eps Current Year | -9.604264 |
| Price Hint | 2 |
| Price To Book | 3.4547286 |
| Profit Margins | 0.0 |
| Quick Ratio | 24.888 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.16667 |
| Region | US |
| Regular Market Change | -0.719999 |
| Regular Market Change Percent | -2.91262 |
| Regular Market Day High | 24.84 |
| Regular Market Day Low | 23.94 |
| Regular Market Day Range | 23.94 - 24.84 |
| Regular Market Open | 24.74 |
| Regular Market Previous Close | 24.72 |
| Regular Market Price | 24.0 |
| Regular Market Time | 1,792,180,800 |
| Regular Market Volume | 70,647 |
| Sand P52 Week Change | 0.13723719 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 33,447,979 |
| Shares Percent Shares Out | 0.0375 |
| Shares Short | 1,253,724 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 1,096,948 |
| Short Name | SpyGlass Pharma, Inc. |
| Short Percent Of Float | 0.1129 |
| Short Ratio | 8.86 |
| Source Interval | 15 |
| State | CA |
| Symbol | SGP |
| Target High Price | 62.0 |
| Target Low Price | 37.0 |
| Target Mean Price | 44.0 |
| Target Median Price | 42.0 |
| Total Cash | 234,186,000 |
| Total Cash Per Share | 7.001 |
| Total Debt | 1,632,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.51 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 24.077658 |
| Two Hundred Day Average Change | -0.0776577 |
| Two Hundred Day Average Change Percent | -0.0032253012 |
| Type Disp | Equity |
| Volume | 70,647 |
| Website | https://www.spyglasspharma.com |
| Zip | 92,618 |